Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

97
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
97
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

109
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
109
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

157
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
157
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

369
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
369
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

191
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
191
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

184
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
184

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart failure and renal outcomes with angiotensin receptor blockers compared with calcium channel blockers in patients with chronic kidney disease: a target trial emulation.

Heart (British Cardiac Society)·2026
Same author

Risk of urinary tract infection with SGLT2 inhibitor initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A target trial emulation using a Japanese hospital-based claims database.

Journal of diabetes investigation·2026
Same author

Influence Analyses of "Designs" for Evaluating Inconsistency in Network Meta-Analysis.

Statistics in medicine·2026
Same author

Smartphone CBT engagement and depressive symptoms: secondary analysis of the RESiLIENT trial using a time-varying exposure approach.

Psychological medicine·2026
Same author

Angiotensin Receptor Blockers Versus Calcium Channel Blockers for First-Line Antihypertensive Therapy and Survival in Adults Aged 75 Years or Older.

Journal of the American Geriatrics Society·2026
Same author

Platform trial of smartphone-based cognitive-behavioural therapy (CBT) for depressive symptoms among people with no or subthreshold depression: a protocol for the Best, Efficient and Affordable Training in Resilience in Constant Evolution (BEATRICE) platform trial.

BMJ open·2026
Same journal

Targeted maximum likelihood estimation (TMLE) in regulatory submissions and research: a landscape analysis.

The international journal of biostatistics·2026
Same journal

Predicting birth weight by multivariate functional principal component regressions.

The international journal of biostatistics·2026
Same journal

Robust median regression for count data with general lower truncation using a contaminated discrete Weibull model.

The international journal of biostatistics·2026
Same journal

Handling the uncertainty issue of missingness via a mixture-structure-based method.

The international journal of biostatistics·2026
Same journal

Statistical method for pooling categorical biomarker data from multi-center matched/nested case-control studies.

The international journal of biostatistics·2026
Same journal

Prognostic score methods for the estimation of the average causal effect.

The international journal of biostatistics·2026
See all related articles

Related Experiment Video

Updated: Jul 24, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.4K

Bayesian estimation and prediction for network meta-analysis with contrast-based approach.

Hisashi Noma1

  • 1Department of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan.

The International Journal of Biostatistics
|July 4, 2023
PubMed
Summary
This summary is machine-generated.

New Bayesian methods simplify network meta-analysis for comparing multiple treatments. These techniques avoid complex computations and allow direct posterior sampling, enhancing clinical epidemiology research.

Keywords:
Bayesian analysiscontrast-based approachimproper priornetwork meta-analysisnoninformative prior

More Related Videos

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

11.2K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K

Related Experiment Videos

Last Updated: Jul 24, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.4K
Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

11.2K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K

Area of Science:

  • Clinical Epidemiology
  • Health Technology Assessment
  • Biostatistics

Background:

  • Network meta-analysis (NMA) is crucial for assessing comparative treatment effectiveness.
  • Bayesian methods, particularly reference analyses with noninformative priors, are standard for arm-based NMA.
  • Existing methods often rely on iterative computations like Markov chain Monte Carlo (MCMC).

Purpose of the Study:

  • To introduce generic Bayesian analysis methods for the contrast-based approach in NMA.
  • To enable direct posterior and posterior predictive distribution sampling without MCMC.
  • To provide a flexible framework accommodating both proper and improper prior distributions.

Main Methods:

  • Developed generic Bayesian methods for contrast-based NMA.
  • Incorporated direct sampling techniques, bypassing iterative computations.
  • Included representative noninformative priors, such as the Jeffreys prior.
  • Created an R package (BANMA) for practical implementation.

Main Results:

  • The proposed methods allow direct sampling from posterior distributions, eliminating the need for convergence checks.
  • The framework handles various prior distributions, including noninformative types.
  • The BANMA package offers a user-friendly interface for applying these methods.

Conclusions:

  • The novel Bayesian methods offer a computationally efficient and accessible approach to contrast-based NMA.
  • These advancements facilitate broader application of Bayesian techniques in health technology assessments.
  • The BANMA package simplifies the implementation of advanced Bayesian NMA.